Marimed (MRMD) Short term Debt (2011 - 2023)

Marimed's (MRMD) quarterly Short term Debt came in at $3.6 million in Q3 2023, little changed quarter-over-quarter from $3.6 million in Q2 2023.

Analysis

Marimed (MRMD) Short term Debt (2011 - 2023) Analysis & Trends

Marimed (MRMD) has reported Short term Debt for 7 consecutive years, with $3.6 million the latest figure, recorded in Q3 2023.

On a quarterly basis, Short term Debt changed N/A year-over-year to $3.6 million in Q3 2023; TTM through Sep 2023 was $3.6 million, a N/A change from a year earlier, with the FY2015 full-year figure at $680320.0, up 1043.66% from the prior year.
Short term Debt was $3.6 million for Q3 2023 at Marimed, roughly flat from $3.6 million in the prior quarter.
Over five years, Short term Debt peaked at $3.6 million in Q2 2023 and troughed at $3.3 million in Q1 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Curaleaf Holdings	2.66 Bn	2.56 Bn	169.91 Mn
2	Trulieve Cannabis	2.27 Bn	1.94 Bn	162.29 Mn
3	Green Thumb Industries	1.71 Bn	1.42 Bn	137.87 Mn
4	Cronos	1.18 Bn	379.85 Mn	28.45 Mn
5	Glass House Brands	666.14 Mn	647.59 Mn	15.77 Mn
6	Vireo Growth	545.10 Mn	402.80 Mn	95.30 Mn
7	Tilray Brands	470.81 Mn	236.18 Mn	90.52 Mn
8	Verano Holdings	434.44 Mn	349.24 Mn	99.70 Mn
9	Canopy Growth	406.26 Mn	159.25 Mn	16.08 Mn
10	Marimed	32.09 Mn	21.75 Mn	16.23 Mn

Historic Data

Download Data